Biolevate's appearance on BFM Business highlighted Biolevate Platform. This media exposure provides an exceptional showcase to present their vision and innovations to the general public.

Reel IT Groupe, a leader in digital transformation, and Biolevate, a pioneering start-up in Artificial Intelligence, today announce the signing of an exclusive strategic partnership. This collaboration aims to radically transform the management and analysis of unstructured data.

Biolevate, a Paris-based start-up founded in 2023, has raised 6 million euros to develop Biolevate Platform, an artificial intelligence platform dedicated to the management and creation of scientific documents in the pharmaceutical industry. This solution aims to optimize document production, reduce time-to-market for treatments and guarantee regulatory compliance. The funding round, led by EQT Ventures, will enable Biolevate to expand its team and strengthen Biolevate Platform's technological development.

Biolevate selected as a Future 40 startup at STATION F, accelerating healthcare innovation with ethical AI.

In the fast-paced world of life sciences research, staying up-to-date with the latest scientific literature is crucial.

In the complex landscape of life sciences research, effective collaboration and project management are crucial for success.

In the rapidly evolving field of life sciences, researchers and medical professionals face the challenge of managing vast amounts of complex data efficiently. Biolevate, a company at the forefront of scientific innovation, has developed an innovative approach to address this need through its AI-assisted knowledge management platform.

A few weeks ago, I had the opportunity to give a speech on AI's impact on business to a community of entrepreneurs and business leaders. This neutral exercise helped solidify an important idea: while loud promises about catchy business expectations often dominate the conversation, a beautiful silent revolution is occurring in many domains of expertise. The community that might benefit the most in the short term is likely researchers and scientists.

Biolevate’s new Metadata feature in Biolevate Platform streamlines data processing, boosts efficiency, and enhances security for users.

Biolevate’s new METADATA feature transforms data accuracy, compliance, and productivity in therapeutic research with advanced AI automation.

Biolevate accelerates therapeutic research with AI-driven tools, improving collaboration, compliance, and speeding new therapies to market.